Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5,071,025
-
Number of holders
-
221
-
Total 13F shares, excl. options
-
18,681,380
-
Shares change
-
-186,225
-
Total reported value, excl. options
-
$2,812,961,739
-
Value change
-
-$21,728,607
-
Put/Call ratio
-
35%
-
Number of buys
-
110
-
Number of sells
-
104
-
Price
-
$150.61
Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2015
As of 30 Jun 2015 BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) had 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,681,380 shares of stock of the company.
Largest 10 holders included ATLANTA CAPITAL MANAGEMENT CO L L C, VANGUARD GROUP INC, ARIEL INVESTMENTS, LLC, BlackRock Fund Advisors, LEVIN CAPITAL STRATEGIES, L.P., BlackRock Institutional Trust Company, N.A., WELLS FARGO & COMPANY/MN, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, ACADIAN ASSET MANAGEMENT LLC, and STATE STREET CORP.
This table shows 249 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.